Mobile Platform for Opioid Use Disorder and Alcoholism

(MPOWER Trial)

This trial explores a new method to assist individuals with both opioid and alcohol use disorders. It employs a digital platform that provides support and rewards to encourage adherence to treatment and sobriety. Participants will be divided into two groups: one will use a digital program focused on motivation and support (Digital Contingency Management Intervention Arm), while the other will use a wellness platform offering resources like surveys and tech support (Digital Wellness Arm). Individuals who have been on specific opioid treatments, have alcohol use issues, are on Michigan Medicaid, and possess a smartphone may be suitable candidates. As an unphased trial, this study presents a unique opportunity to contribute to innovative research that could influence future treatment options.

The trial does not specify if you need to stop taking your current medications. However, you must be on opioid agonist treatment with buprenorphine or methadone to participate.

Research has shown that digital contingency management (CM) is generally well-received by people with substance use disorders. Studies have found that digital CM tools can help patients adhere to their treatment plans and reduce substance use. For instance, one study found that patients using a digital CM tool had 35% fewer days of opioid use.

Few reports of serious side effects or negative events with digital CM suggest it is a safe option for those seeking help for opioid and alcohol use disorders. Digital platforms for treatment also provide extra convenience and support, making it easier for participants to stay engaged in their recovery.

Researchers are excited about these digital interventions for opioid use disorder and alcoholism because they offer a novel approach to treatment through technology. The Digital Contingency Management Intervention Arm uses a comprehensive digital platform that not only supports motivation but also aims to improve retention in opioid agonist therapy (OAT) and encourage abstinence from substances. This contrasts with traditional treatments like medication-assisted therapy and counseling by integrating behavioral incentives with digital tools. Meanwhile, the Wellness Condition offers participants a unique digital platform focusing on wellness through surveys and tech support, which could enhance user engagement and accessibility. These digital solutions have the potential to reach more people more conveniently, providing a personalized and supportive experience.

Research shows that digital contingency management (CM), which participants in this trial may receive, can help treat substance use disorders. Studies have found that people using digital CM apps like DynamiCare are more likely to stay away from drugs and alcohol than those who don't use these apps. Digital CM offers rewards for staying drug-free, boosting motivation and accountability. Results from similar patient groups showed that those using digital CM had much better outcomes. This method holds promise for helping people with opioid and alcohol use disorders achieve and maintain recovery. Meanwhile, another group in this trial will receive a wellness digital platform, which includes surveys, testing, and tech support, to compare its effectiveness.²³⁶⁷⁸